ITGR Stock - Integer Holdings Corporation
Unlock GoAI Insights for ITGR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.72B | $1.56B | $1.33B | $1.22B | $1.07B |
| Gross Profit | $461.18M | $411.52M | $346.65M | $336.97M | $285.71M |
| Gross Margin | 26.9% | 26.5% | 26.0% | 27.6% | 26.6% |
| Operating Income | $208.24M | $163.32M | $112.68M | $135.71M | $120.61M |
| Net Income | $119.90M | $90.65M | $66.38M | $96.81M | $77.26M |
| Net Margin | 7.0% | 5.8% | 5.0% | 7.9% | 7.2% |
| EPS | $3.60 | $2.72 | $1.97 | $2.82 | $2.35 |
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 24th 2025 | Argus | Downgrade | Hold | - |
| October 24th 2025 | Wells Fargo | Downgrade | Equal Weight | $80 |
| October 24th 2025 | Citigroup | Downgrade | Neutral | $77 |
| October 24th 2025 | BofA Securities | Downgrade | Neutral | $87 |
| October 24th 2025 | The Benchmark Company | Downgrade | Hold | - |
| May 22nd 2025 | Citigroup | Upgrade | Buy | $140 |
| March 28th 2025 | Raymond James | Initiation | Outperform | $145 |
| February 21st 2025 | Oppenheimer | Downgrade | Perform | - |
| December 3rd 2024 | Wells Fargo | Resumed | Overweight | $160 |
| July 16th 2024 | Oppenheimer | Initiation | Outperform | $135 |
| May 15th 2024 | Truist | Initiation | Buy | $137 |
| April 15th 2024 | BofA Securities | Upgrade | Buy | $135← $105 |
| March 14th 2024 | CL King | Initiation | Buy | $137 |
| February 6th 2024 | KeyBanc Capital Markets | Resumed | Overweight | $125 |
| May 26th 2023 | Wells Fargo | Initiation | Equal Weight | $87 |
Earnings History & Surprises
ITGREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 22, 2026 | — | — | — | — |
Q1 2026 | Feb 19, 2026 | $1.70 | — | — | — |
Q4 2025 | Oct 23, 2025 | $1.68 | $1.79 | +6.5% | ✓ BEAT |
Q3 2025 | Jul 24, 2025 | $1.57 | $1.55 | -1.3% | ✗ MISS |
Q2 2025 | Apr 24, 2025 | $1.27 | $1.31 | +3.1% | ✓ BEAT |
Q1 2025 | Feb 20, 2025 | $1.46 | $1.43 | -2.1% | ✗ MISS |
Q4 2024 | Oct 24, 2024 | $1.36 | $1.43 | +5.1% | ✓ BEAT |
Q3 2024 | Jul 25, 2024 | $1.24 | $1.30 | +4.8% | ✓ BEAT |
Q2 2024 | Apr 25, 2024 | $1.12 | $1.14 | +1.8% | ✓ BEAT |
Q1 2024 | Feb 15, 2024 | $1.34 | $1.39 | +3.7% | ✓ BEAT |
Q4 2023 | Oct 26, 2023 | $1.05 | $1.27 | +21.0% | ✓ BEAT |
Q3 2023 | Jul 27, 2023 | $0.99 | $1.14 | +15.2% | ✓ BEAT |
Q2 2023 | Apr 27, 2023 | $0.82 | $0.87 | +6.1% | ✓ BEAT |
Q1 2023 | Feb 16, 2023 | $1.05 | $1.11 | +5.7% | ✓ BEAT |
Q4 2022 | Oct 27, 2022 | $0.89 | $0.95 | +6.7% | ✓ BEAT |
Q3 2022 | Jul 28, 2022 | $1.18 | $1.04 | -11.9% | ✗ MISS |
Q2 2022 | Apr 28, 2022 | $0.89 | $0.78 | -12.4% | ✗ MISS |
Q1 2022 | Feb 17, 2022 | $0.96 | $0.99 | +3.1% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $0.96 | $1.05 | +9.4% | ✓ BEAT |
Q3 2021 | Jul 29, 2021 | $0.81 | $1.07 | +32.1% | ✓ BEAT |
Latest News
Truist Securities Maintains Buy on Integer Holdings, Raises Price Target to $95
📈 Positive'Activist Irenic Pushing Medical-Device Maker Integer to Pursue Sale'- WSJ
➖ NeutralCitigroup Maintains Neutral on Integer Holdings, Raises Price Target to $75
➖ NeutralTruist Securities Maintains Buy on Integer Holdings, Lowers Price Target to $86
📈 PositiveInteger Holdings Corporation Board Authorizes $200M Share Repurchase Program
📈 PositiveCitigroup Maintains Neutral on Integer Holdings, Lowers Price Target to $69
➖ NeutralTruist Securities Maintains Buy on Integer Holdings, Lowers Price Target to $88
➖ NeutralRaymond James Reiterates Outperform on Integer Holdings, Lowers Price Target to $95
📈 PositivePiper Sandler Maintains Overweight on Integer Holdings, Lowers Price Target to $82
➖ NeutralBenchmark Downgrades Integer Holdings to Hold
📉 NegativeKeybanc Maintains Overweight on Integer Holdings, Lowers Price Target to $93
➖ NeutralWells Fargo Downgrades Integer Holdings to Equal-Weight, Lowers Price Target to $80
📉 NegativeCitigroup Downgrades Integer Holdings to Neutral, Lowers Price Target to $77
📉 NegativeInteger Holdings Lowers FY2025 GAAP EPS Guidance from $2.79-$3.05 to $2.70-$2.84 vs $2.99 Est
📉 NegativeInteger Holdings Narrows FY2025 Adj EPS Guidance from $6.25-$6.51 to $6.29-$6.43 vs $6.36 Est; Lowers FY2025 Sales Guidance from $1.850B-$1.876B to $1.840B-$1.854B vs $1.866B Est
📉 NegativeInteger Holdings Q3 Adj. EPS $1.79 Beats $1.68 Estimate, Sales $467.691M Beat $466.452M Estimate
📈 PositiveKeybanc Maintains Overweight on Integer Holdings, Lowers Price Target to $133
➖ NeutralTruist Securities Maintains Buy on Integer Holdings, Lowers Price Target to $121
➖ NeutralFrequently Asked Questions about ITGR
What is ITGR's current stock price?
What is the analyst price target for ITGR?
What sector is Integer Holdings Corporation in?
What is ITGR's market cap?
Does ITGR pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ITGR for comparison